These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33494881)

  • 41. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH.
    Chuang MT; Chang CH
    Taiwan J Obstet Gynecol; 2022 Sep; 61(5):896-899. PubMed ID: 36088064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal management and outcome in alloimmune hemolytic disease.
    Ree IMC; Smits-Wintjens VEHJ; van der Bom JG; van Klink JMM; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Jul; 10(7):607-616. PubMed ID: 28503958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
    Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
    Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn?
    Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of mild HDFN caused by anti-C, anti-D, and anti-G: Diagnostic strategy and clinical significance of distinguishing anti-G from anti-D and anti-C.
    Chen J; Liu F
    Transfus Apher Sci; 2020 Feb; 59(1):102602. PubMed ID: 31303507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti-U: A case report.
    Badawi MA; Al-Wassia H
    Transfusion; 2023 Feb; 63 Suppl 1():S28-S32. PubMed ID: 36748668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jr
    Ohto H; Denomme GA; Ito S; Ishida A; Nollet KE; Yasuda H
    Transfus Apher Sci; 2020 Oct; 59(5):102949. PubMed ID: 32994126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.
    Zuppa AA; Cardiello V; Lai M; Cataldi L; D'Andrea V; Romagnoli C
    Transfusion; 2010 Oct; 50(10):2102-4. PubMed ID: 20492611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood product replacement in the perinatal period.
    Wu Y; Stack G
    Semin Perinatol; 2007 Aug; 31(4):262-71. PubMed ID: 17825684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
    Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn.
    Quantock KM; Lopez GH; Hyland CA; Liew YW; Flower RL; Niemann FJ; Joyce A
    Transfusion; 2017 Aug; 57(8):1938-1943. PubMed ID: 28639307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.
    Jain A; Malhotra S; Marwaha N; Kumar P; Sharma RR
    Asian J Transfus Sci; 2018; 12(2):176-179. PubMed ID: 30692807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noninvasive approach for the management of hemolytic disease of the fetus.
    Illanes S; Soothill P
    Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions.
    Strindberg J; Lundahl J; Ajne G
    Immunohematology; 2013; 29(2):51-4. PubMed ID: 24094236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen.
    Páez M; Jiménez M; Corredor A
    Biomedica; 2021 Dec; 41(4):643-650. PubMed ID: 34936250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
    Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
    Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.